AlphaOS

Coverage building

RADX has basic price and filing data (45% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.

Deeper coverage nearby

Intelligence coverage: 45%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

RADX

Radiopharm Theranostics Ltd

Healthcare · Biotechnology

$1.63Sep 23, 2026

AI confidence 50% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for RADX yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 68d ago

AlphaOS Signals
Upgrade to Premium

Latest Intelligence

Updated

What happened recently for Radiopharm Theranostics Ltd (RADX) — events, not interpretation.

Event
Last session September 23, 2026 at $1.63.
Source
Market data

Research & analysis only — not investment advice.

Loading earnings intelligence…

Radiopharm Theranostics Ltd (RADX)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for Radiopharm Theranostics Ltd — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotechnology
Market cap:
$3.84B

RADX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Radiopharm Theranostics Ltd through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Themes

Radiopharm Theranostics Ltd (RADX) in AlphaOS research

Related & Connected

Related

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.